InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (8 ops.)
Explore the complete record of transactions filed by Labrucherie Gil M, Chief Financial Officer. Director active across 3 companies, notably NEKTAR THERAPEUTICS. Aggregated, 15 reports have been logged. Total volume traded: €1.4m. The latest transaction was disclosed on 15 May 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations15 total
028,750 shares0
Common Stock
SEC:0001209191-22-029899:0·
€188,27852,631 shares@ €3.57730.049% mcap50.0% of flow
Common Stock
SEC:0001567619-22-009789:0·
Ideal exit: 29 Jan 2023 (T+270)
€188,27852,631 shares@ €3.57730.049% mcap50.0% of flow
Common Stock
SEC:0001567619-22-009699:0·
Ideal exit: 29 Jan 2023 (T+270)
€73,0757,579 shares@ €9.64180.0031% mcap6.9% of flow
Common Stock
SEC:0001209191-22-011436:0·
€73,0757,579 shares@ €9.64180.0031% mcap13.8% of flow
Common Stock
SEC:0001209191-22-011436·
052,950 shares0
Common Stock
SEC:0001209191-21-070690·
052,950 shares0
Common Stock
SEC:0001209191-21-070690:0·
€244,86121,149 shares@ €11.57790.010% mcap46.3% of flow
Common Stock
SEC:0001209191-21-065592·
€244,86121,149 shares@ €11.57790.010% mcap23.1% of flow
Common Stock
SEC:0001209191-21-065592:0·
040,150 shares0
Common Stock
SEC:0001209191-21-065220·
040,150 shares0
Common Stock
SEC:0001209191-21-065220:0·
€92,3617,867 shares@ €11.74030.0039% mcap17.5% of flow
Common Stock
SEC:0001209191-21-052384·
€92,3617,867 shares@ €11.74030.0039% mcap8.7% of flow
Common Stock
SEC:0001209191-21-052384:0·
€118,8907,898 shares@ €15.05320.0050% mcap22.5% of flow
Common Stock
SEC:0001209191-21-034184·
€118,8907,898 shares@ €15.05320.0050% mcap11.2% of flow
Common Stock
SEC:0001209191-21-034184:0·
15 of 15 declarations
About Labrucherie Gil M
Gil M Labrucherie is an executive at NEKTAR THERAPEUTICS.
